Title : Abnormal centrosome-centriole cycle in chronic myeloid leukaemia?

Pub. Date : 2009 Aug

PMID : 19563513






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Furthermore, when CML cells were treated with imatinib there was a 55% and 20% reduction of p210(BCR-ABL1) and p145(ABL1) binding to pericentrin, respectively. Imatinib Mesylate POM121 transmembrane nucleoporin Homo sapiens